New
SM
Clara Fargo
EBMT Clinical Research Quality Assurance Coordinator
I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...
Serious Adverse Event (SAE) Reporting & Case Processing Course & Certification
Intermediate
4.7
★★★★★
93% Recommended
2 hours
167 active users
3 points
Your Study Basket
Serious Adverse Event (SAE) Reporting & Case Processing
| Total | |
🎁 FREE Bonus Included
eBookWorth £29— Yours FREE when you purchase today.
VAT is levied as per your country’s applicable rules and rates at checkout
Save more with a monthly or annual plan that includes this course
Secure Payment Service
Rest assured we use secure processes to protect your payment.
Secured by:
About
Serious Adverse Event (SAE) reporting is a critical component of clinical research and pharmacovigilance that helps ensure participant safety and regulatory compliance. Timely identification, assessment, documentation, and reporting of SAEs are essential for monitoring the safety profile of investigational and marketed medicinal products.
This Serious Adverse Event (SAE) Reporting & Case Processing Course & Certification provides comprehensive training on SAE definitions, regulatory requirements, seriousness determination, severity assessment, expectedness, causality evaluation, reporting timelines, documentation standards, case processing procedures, follow-up activities, quality oversight, and inspection readiness. Learners will gain practical knowledge of safety reporting workflows and best practices for managing safety information throughout the product lifecycle. Upon successful completion, participants receive a certification demonstrating their understanding of SAE reporting and case processing requirements.
Who Should Enrol?
- Clinical Research Associates (CRAs)
- Clinical Trial Coordinators and Study Site Personnel
- Pharmacovigilance and Drug Safety Professionals
- Clinical Research Professionals and Investigators
- Medical Monitors and Safety Physicians
- Regulatory Affairs Professionals
- Quality Assurance and Compliance Personnel
- Students and Entry-Level Professionals pursuing careers in Clinical Research or Pharmacovigilance
What you will learn
Understand the regulatory requirements, definitions, and principles governing Serious Adverse Event (SAE) reporting in clinical research and pharmacovigilance.
Learn how to assess seriousness, severity, expectedness, and causality to determine appropriate reporting obligations and timelines.
Develop knowledge of SAE documentation, case intake, data collection, follow-up activities, and case processing workflows.
Gain understanding of regulatory reporting requirements, quality oversight, inspection readiness, and the management of special safety situations.
Course Syllabus
- Safety Reporting Is the Backbone of Ethical Research
- From Individual Reports to Systemic Protection
- What Counts as an Adverse Event (AE)?
- AE Building Blocks — What to Capture
- What Makes an Adverse Event 'Serious'?
- Three Distinctions That Trip People Up
- The Safety Terminology Hierarchy
- How the Three Filters Combine
- The Classification Decision Flow
- The Global Framework Governing SAE Reporting
- Key Instruments at a Glance
- Safety Reporting From First Dose to Close-Out
- Aggregate Reporting Complements Expedited Reporting
- The Cost of Getting Safety Reporting Wrong
- Four Dimensions of Failure
- Safety Data Drives Real Decisions
- The Safety Documents That Evolve With the Data
- AE Collection: What the Protocol Decides
- The Distinction That Inspectors Test
- Building a Reporting Culture That Protects Patients
- Investigator vs Sponsor Obligations in Brief
- Trials, Post-Marketing + the Reporting Difference
- First-in-Human: When Vigilance Matters Most
- Three Pillars of Trial Safety Governance
- How Reporting Failures Actually Happen
- Strong vs Weak SAE Handling — A Preview
- Serious Is a Defined Term, Not an Opinion
- The Seriousness Checklist (ICH E2A)
- Death as an Outcome, Not an Event
- Life-Threatening Means At Risk Now
- Inpatient Admission and Its Boundaries
- Admission Scenarios — Serious or Not?
- Persistent or Significant Disability
- Birth Defects in Exposed Offspring
- The Judgement-Based Catch-All
- Examples Often Captured Here
- When the Checklist Isn't Enough
- A Structured Seriousness Determination
- Under-Reporting vs Over-Reporting
- The Role of the Medical Monitor
- Handling and Following Up Fatal Cases
- Three Settings, Same Criteria
- Making the Determination Inspection-Ready
- The Field Card Assessors Keep
- Defensible vs Indefensible Determinations
- Embedding Seriousness Assessment at Sites
- Seriousness Across FDA + EU Frameworks
- When SAEs May Be Exempt From Immediate Reporting
- Why Accurate Seriousness Protects the Whole Programme
- Three Habits of Strong Assessors
- Rapid-Fire Seriousness Calls
- Seriousness Errors Inspectors See Repeatedly
- Two Words, Two Completely Different Jobs
- Common Severity Scales in Clinical Research
- Using CTCAE and Grading Scales Well
- Expected vs Unexpected — The RSI Test
- What the RSI Is and Why It Governs
- The IB and Its Safety Role
- The Core Principles
- Common Causality Assessment Approaches
- A Structured Causality Workflow
- Weighing the Evidence
- Combining the Three Assessments
- What Each Combination Requires
- Edge Cases That Need Care
- Oncology Example — Expected Toxicity vs Reportable Signal
- Vaccine Example — Reactogenicity vs Adverse Reaction
- Medical Device Example — Event vs Device Deficiency
- Defensible vs Weak Assessments
- Making Reportability Inspection-Ready
- Why the Confusion Causes Real Harm
- Three Ways an Event Can Be Unexpected
- Controlling the Document That Defines SUSARs
- Assessing Expectedness Step by Step
- Dual Assessment by Investigator and Sponsor
- Weighing For and Against Relatedness
- Assessing and Reporting Without Breaking the Blind
- Severity, Expectedness, Causality by Setting
- Keeping Determinations Consistent at Scale
- The First Link in the Chain
- The Hub of Safety Reporting
- Delegated Activities, Defined in Writing
- The Engine Room of Case Handling
- Clinical Oversight Across the Programme
- IRB / IEC Reporting Obligations
- Reporting Obligations to FDA, EMA, MHRA
- The SAE Information Flow
- Who Does What in SAE Reporting
- Using RACI to Close the Gaps
- Three Common Operating Models
- Escalating a Fatal Event
- When and How to Escalate
- Oversight Failure — The Gap Between Sponsor and CRO
- When One Party Wears Two Hats
- Clear vs Unclear Responsibility Models
- Keeping the Pathways Reliable
- What 'Immediately' Means in Practice
- Three Layers of the Safety Operation
- Distinguishing Medical Monitor From Safety Physician
- Where Most Timelines Are Won or Lost
- Who Reports What to Whom
- Coordinating Sponsor and Investigator Reporting
- Submission Systems and Formats
- How Sponsors Evidence CRO Oversight
- Beyond the Individual Case
- Communication Breakdown — The Lost SAE
- Making Roles Real at Every Site
- Centralised PV vs Distributed Responsibility
- The End-to-End Reporting Workflow
- Starting the Process Right
- What the Site Must Do
- From Receipt to Decision
- The Core SUSAR Clocks
- The Shortest, Highest-Priority Clocks
- Cases Are Living Documents
- A SUSAR From Day-Zero to Submission
- Who Must Receive the Report
- Comparing Major Frameworks
- Managing One Event Across Many Regulators
- Timeline Failure — The Weekend Fatality
- Getting the Clock Start Right
- On-Time vs At-Risk Reporting Operations
- Tracking and Protecting Compliance
- The Four Minimum Elements
- From Receipt to Triage
- Common Site-Level Failure Modes
- Three Habits of Effective Follow-Up
- When Follow-Up Becomes Expedited
- Reading the Differences That Matter
- Other SUSAR — The 15-Day Path
- Protecting the Blind While Reporting
- Closing the Often-Missed Loop
- How Expedited and DSUR Reporting Connect
- Global Reporting — One Event, Four Authorities
- Why Reports Go Late
- Designing a Reliable Reporting Operation
- Two Clocks, Two Postures
- The Foundation of Every SAE Report
- Source Records Behind a Typical SAE
- Working With Hospital and External Records
- Completing the Form Correctly
- Principles of a Good SAE Narrative
- A Reliable Narrative Template
- What 'Quality' Means for SAE Data
- Handling the Gaps Properly
- Recording How a Case Evolves
- Demonstrating Integrity Over Time
- Example SAE Report — Anatomy of a Good Case File
- Strong vs Weak SAE Documentation
- Documentation Mistakes Inspectors Find
- Documentation That Withstands Scrutiny
- The Data-Integrity Principles That Govern SAE Records
- Three Consistency Checks That Prevent Findings
- What Makes a Narrative Fail Review
- What Every SAE Narrative Must Contain
- Turning Gaps Into Managed Follow-Up
- Built-In Documentation QC Before Submission
- Using the Trail to Assure Integrity
- Three Requirements for the Case File
- A Field Guide to Avoidable Findings
- Common Error — The Inconsistent Day-Zero
- Consistent vs Variable Narrative Quality
- Versioning a Case Across Its Life
- Handling Personal Data in SAE Files
- From Intake to Closure
- The System at the Centre
- Getting Cases Into the System Right
- Consistency at the Keyboard
- Why Coding Matters
- The Medical Dictionary for Regulatory Activities
- From Reporter Term to System Organ Class
- Prioritising What Matters Most
- QC Within Case Processing
- What Reviewers Check
- Knowing When a Case Is Done
- Keeping Safety and Clinical Data Aligned
- PV Operations — A Day in the Safety Database
- Strong vs Weak Case Processing
- Measuring Case-Processing Health
- Three Things the System Must Do
- Finding the Same Case Twice
- E2B(R3) Data Elements in Practice
- From Reporter Term to Coded Case
- Avoiding the Two Coding Failures
- Decisions Made in the First Minutes
- Tracking a Case Through the System
- Designing QC That Adds Value
- Controlled End States
- Reconciliation Gap — The Case That Wasn't in Safety
- Processing in an Outsourced World
- Beyond the Classic Adverse Event
- Reporting and Following to Outcome
- Exposure Through Lactation
- Capturing How Things Go Wrong
- Intentional and Accidental
- Use Outside the Intended Way
- Exposure of Non-Participants
- When Quality Meets Safety
- When the Product Doesn't Work
- Reporting Expectations Summary
- Special Situation — Pregnancy in an Oncology Trial
- Special Situation — Medication Error Causing Harm
- Strong vs Weak Practice
- Three Situations Followed to Outcome
- Building Robust Pregnancy Handling
- A Taxonomy of Error Types
- Capturing the Exposure and Its Effects
- Why Misuse and Abuse Data Carry Weight
- Coordinating PV and Quality Assurance
- Special Situation — Vaccine Lack of Efficacy
- Exposure Beyond the Protocol
- Flagged vs Missed Special Situations
- What GVP Module VI Expects
- Further Situations Worth Capturing
- Special Situations in Practice
- Routing Each Scenario Correctly
- The QMS Around Safety Reporting
- The Operational Blueprint
- Completeness as a Quality Control
- How Reconciliation Works
- Overseeing Delegated Safety Activities
- Three Pillars of Evidenced Oversight
- Being Ready Before the Inspector Arrives
- Handling the Inspection Well
- Corrective and Preventive Action
- MHRA Inspection Theme — Late SUSAR Reporting
- FDA Warning Letter Theme — Safety Reporting Failures
- Building a Strengthening System
- Inspection-Ready vs At-Risk Operations
- Focusing Effort Where It Matters
- Safety-System KPIs Worth Reviewing
- Making Reconciliation Reliable
- Evidencing Oversight Across Vendor Types
- The Always-Ready Document Set
- From Finding to Verified Closure
- Getting Past the First Answer
- Sponsor Audit — Catching a Gap Before the Regulator
- Closing the Quality Loop at the Top
- Reactive vs Proactive Quality Culture
- People as a Quality Control
- Turning Common Findings Into Controls
- How We Work Each Case
- Hospitalisation After IP
- What Case 1 Teaches
- Unexpected Serious Liver Injury
- What Case 2 Teaches
- Pregnancy Exposure
- What Case 3 Teaches
- Medication Error With Harm
- What Case 4 Teaches
- Life-Threatening Reaction
- What Case 5 Teaches
- Multi-Country SUSAR
- What Case 6 Teaches
- Six Cases, One Framework
- hat the Six Cases Share
- Inspection-Ready vs At-Risk Case Handling
- Expected Serious Reaction
- Building a Defensible DILI Case
- Following the Pregnancy to Outcome
- Fixing the Dispensing System
- Life-Threatening SUSAR Timeline
- Managing One Event Across Four Regulators
- How Each Module Shows Up in the Cases
- 📘 Bonus: Serious Adverse Event (SAE) reporting eBook (Free with purchase)
Course Benefits
Free eBook
Get our exclusive eBook with every purchase - a complete companion guide to the course, yours to keep forever
CPD Points
Gain Continuing Professional Development (CPD) Points, accredited by The Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. These can be used to count towards the distance learning element of any scheme that comes under the umbrella of The Academy of Medical Royal Colleges or any other scheme for which there is mutual recognition.
Certification
Receive a personal certificate to show your subject knowledge on course completion.
Affordable
You get excellent value through our cost-effective prices. We can also offer you group discounts on larger purchases.
Flexibility
The course saves you time through the convenience of online availability. This lets you complete the interactive course at your own comfort.
Keep Up to Date
You will stay up to date with any changes to ICH E6(R3), ICH E2A, ICH E2B(R3), EU Clinical Trials Regulation 536/2014, and FDA, EMA and MHRA safety-reporting requirements, as our training courses are constantly monitored, reviewed and updated.
Learn from Industry Experts
The course content has been developed by pharmacovigilance and clinical research practitioners with case-processing and GCP inspection experience, so that learners can confidently assess, report and document serious adverse events to an inspection-ready standard.
Our Certified Customers
Learner Rating & Reviews
4.7
★★★★★★
Average Rating
536 global ratings
★★★★★
87.0%
★★★★★
5.0%
★★★★★
3.0%
★★★★★
3.0%
★★★★★
2.0%
Best Seller
